Recruiting Multiple Myeloma Studies in Loveland
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple myeloma compared to a combination therapy inclu...
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical benefit from elranatamab monotherapy in the Pfizer-sponsored elranatamab...
About Multiple Myeloma Clinical Trials in Loveland
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 2 multiple myeloma clinical trials recruiting participants in Loveland, CO. These studies are seeking a combined 1,024 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Loveland — FAQ
Are there multiple myeloma clinical trials in Loveland?
Yes, there are 2 multiple myeloma clinical trials currently recruiting in Loveland, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Loveland?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Loveland research site will contact you about next steps.
Are clinical trials in Loveland free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Loveland studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 2 active trials in Loveland are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated March 2, 2026 from ClinicalTrials.gov